|Articles|January 29, 2020
Thorough and Reproducible Analytical Characterization of an Innovator and Biosimilar Pair
Author(s)Agilent Technologies
• Solutions for comparing innovator and biosimilar mAbs • Biosimilar case studies
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
CDC Revises Childhood Immunization Schedule, Shifting Demand Dynamics
2
China Approves First Monthly Biologic for COPD
3
What Are the Benefits of Single-Use in CGT Manufacturing?
4
Industry Outlook 2026: Biopharma Braces for Economic Upheaval While Eyeing AI-Driven Transformation (Part 1)
5